Integral Diagnostics Ltd (IDX) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.074x

Based on the latest financial reports, Integral Diagnostics Ltd (IDX) has a cash flow conversion efficiency ratio of 0.074x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$51.60 Million ≈ $36.51 Million USD) by net assets (AU$693.94 Million ≈ $491.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see IDX company net worth for the company's overall valuation and market capitalisation.

Integral Diagnostics Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Integral Diagnostics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Integral Diagnostics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Integral Diagnostics Ltd ranked by their cash flow conversion efficiency. Explore IDX cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
AAEON Technology Inc TW:6579	-0.020x
Dook Media Group Limited SHE:301025	N/A
Beijing Tianyishangjia New Material Corp Ltd SHG:688033	-0.043x
Sansec Technology Co. Ltd. A SHG:688489	N/A
Tianshui Zhongxing Bio-technology Co Ltd SHE:002772	0.058x
Krishana Phoschem Limited NSE:KRISHANA	-0.341x
CytomX Therapeutics Inc NASDAQ:CTMX	-0.060x
Gansu Engineering Consulting Group Co Ltd SHE:000779	0.030x

Annual Cash Flow Conversion Efficiency for Integral Diagnostics Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Integral Diagnostics Ltd from 2012 to 2025. View current stock price of Integral Diagnostics Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$693.94 Million ≈ $491.01 Million	AU$73.77 Million ≈ $52.20 Million	0.106x	-51.52%
2024-06-30	AU$301.71 Million ≈ $213.48 Million	AU$66.16 Million ≈ $46.81 Million	0.219x	+14.54%
2023-06-30	AU$373.05 Million ≈ $263.96 Million	AU$71.42 Million ≈ $50.53 Million	0.191x	+79.19%
2022-06-30	AU$347.24 Million ≈ $245.70 Million	AU$37.10 Million ≈ $26.25 Million	0.107x	-60.88%
2021-06-30	AU$254.74 Million ≈ $180.24 Million	AU$69.57 Million ≈ $49.23 Million	0.273x	+14.95%
2020-06-30	AU$228.33 Million ≈ $161.56 Million	AU$54.25 Million ≈ $38.39 Million	0.238x	-10.90%
2019-06-30	AU$127.22 Million ≈ $90.02 Million	AU$33.92 Million ≈ $24.00 Million	0.267x	-6.06%
2018-06-30	AU$93.42 Million ≈ $66.10 Million	AU$26.52 Million ≈ $18.76 Million	0.284x	+12.83%
2017-06-30	AU$90.35 Million ≈ $63.93 Million	AU$22.73 Million ≈ $16.08 Million	0.252x	-12.23%
2016-06-30	AU$83.92 Million ≈ $59.38 Million	AU$24.05 Million ≈ $17.02 Million	0.287x	-29.91%
2015-06-30	AU$41.84 Million ≈ $29.60 Million	AU$17.11 Million ≈ $12.11 Million	0.409x	-67.85%
2014-06-30	AU$2.90 Million ≈ $2.06 Million	AU$3.70 Million ≈ $2.61 Million	1.272x	-13.56%
2013-06-30	AU$2.54 Million ≈ $1.80 Million	AU$3.74 Million ≈ $2.65 Million	1.472x	+55.94%
2012-06-30	AU$2.54 Million ≈ $1.80 Million	AU$2.40 Million ≈ $1.70 Million	0.944x	--

About Integral Diagnostics Ltd

AU:IDX Australia Diagnostics & Research

Market Cap

$601.62 Million

AU$850.27 Million AUD

Market Cap Rank

#11393 Global

#291 in Australia

Share Price

AU$2.28

Change (1 day)

-1.72%

52-Week Range

AU$1.94 - AU$2.89

All Time High

AU$5.00